TVM Life Science Ventures VI LP 13D and 13G filings for Albireo Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-10-23 5:05 pm Sale | 2019-11-06 | 13D | Albireo Pharma, Inc. ALBO | TVM Life Science Ventures VI LP | 0 0.000% | -621,761 (Position Closed) | Filing |